Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication
Practice Guideline, May 2024
Read Published ArticleThis practice guideline provides updated evidence-based conclusions and recommendations regarding the effects of antiseizure medications and folic acid supplementation on the prevalence of major congenital malformations, adverse perinatal outcomes, and neurodevelopmental outcomes in children born to people with epilepsy of childbearing potential.
Endorsed by the Child Neurology Society.
Replaces "Management Issues for Women with Epilepsy—Focus on Pregnancy: Teratogenesis and Perinatal Outcomes" (July 2009).
Clinician Tools and Materials
Clinician Summary
Download a PDF summary of this guideline product
Pocket Guideline Clinician Summary
Access a digital interactive summary of the recommendations and other key information from the guideline
Full-length Version
Download a PDF of the full guideline product, including full details of the methodology and data analysis
Quality Measure
Drive high-quality care at your practice or institution by implementing AAN quality measures related to this guideline
好色先生al Materials
Other resources related to this guideline
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.